Anger, J.T.; Dallas, K.B.; Bresee, C.; De Hoedt, A.M.; Barbour, K.E.; Hoggatt, K.J.; Goodman, M.T.; Kim, J.; Freedland, S.J. National prevalence of IC/BPS in women and men utilizing veterans health administration data. Front Pain Res (Lausanne) 2022, 3, 925834, doi:10.3389/fpain.2022.925834.
Suskind, A.M.; Berry, S.H.; Ewing, B.A.; Elliott, M.N.; Suttorp, M.J.; Clemens, J.Q. The prevalence and overlap of interstitial cystitis/bladder pain syndrome and chronic prostatitis/chronic pelvic pain syndrome in men: results of the RAND Interstitial Cystitis Epidemiology male study. J Urol 2013, 189, 141-145, doi:10.1016/j.juro.2012.08.088.
Stephens-Shields, A.J.; Lai, H.H.; Landis, J.R.; Kreder, K.; Rodriguez, L.V.; Naliboff, B.D.; Afari, N.; Sutcliffe, S.; Moldwin, R.; Griffith, J.W.; et al. Clinically Important Differences for Pain and Urinary Symptoms in Urological Chronic Pelvic Pain Syndrome: A MAPP Network Study. J Urol 2023, 209, 1132-1140, doi:10.1097/JU.0000000000003394.
Hanno, P.M.; Erickson, D.; Moldwin, R.; Faraday, M.M.; American Urological, A. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendment. J Urol 2015, 193, 1545-1553, doi:10.1016/j.juro.2015.01.086.
Arora, H.C.; Shoskes, D.A. The enigma of men with interstitial cystitis/bladder pain syndrome. Transl Androl Urol 2015, 4, 668-676, doi:10.3978/j.issn.2223-4683.2015.10.01.
Bradley, C.S.; Gallop, R.; Sutcliffe, S.; Kreder, K.J.; Lai, H.H.; Clemens, J.Q.; Naliboff, B.D.; Multidisciplinary Approach to the Study of Chronic Pelvic Pain Research, N. Long-Term Symptom Trajectories in Urologic Chronic Pelvic Pain Syndrome: A MAPP Research Network Study. Urology 2022, 169, 58-64, doi:10.1016/j.urology.2022.07.045.
Jhang, J.F.; Jiang, Y.H.; Kuo, H.C. Current Understanding of the Pathophysiology and Novel Treatments of Interstitial Cystitis/Bladder Pain Syndrome. Biomedicines 2022, 10, doi:10.3390/biomedicines10102380.
Mykoniatis, I.; Tsiakaras, S.; Samarinas, M.; Anastasiadis, A.; Symeonidis, E.N.; Sountoulides, P. Monoclonal Antibody Therapy for the Treatment of Interstitial Cystitis. Biologics 2022, 16, 47-55, doi:10.2147/BTT.S290286.
Bosch, P.C. A randomized, double-blind, placebo controlled trial of adalimumab for interstitial cystitis/bladder pain syndrome. J Urol 2014, 191, 77-82, doi:10.1016/j.juro.2013.06.038.
Bosch, P.C. A Randomized, Double-blind, Placebo-controlled Trial of Certolizumab Pegol in Women with Refractory Interstitial Cystitis/Bladder Pain Syndrome. Eur Urol 2018, 74, 623-630, doi:10.1016/j.eururo.2018.07.026.
Shin, J.H.; Ryu, C.M.; Yu, H.Y.; Park, J.; Kang, A.R.; Shin, J.M.; Hong, K.S.; Kim, E.Y.; Chung, H.M.; Shin, D.M.; et al. Safety of Human Embryonic Stem Cell-derived Mesenchymal Stem Cells for Treating Interstitial Cystitis: A Phase I Study. Stem Cells Transl Med 2022, 11, 1010-1020, doi:10.1093/stcltm/szac065.
Jhang, J.F.; Lin, T.Y.; Kuo, H.C. Intravesical injections of platelet-rich plasma is effective and safe in treatment of interstitial cystitis refractory to conventional treatment-A prospective clinical trial. Neurourol Urodyn 2019, 38, 703-709, doi:10.1002/nau.23898.
Yu, W.R.; Chang, W.C.; Kuo, H.C. Clinical presentation, videourodynamic characteristics, and treatment outcome in men with interstitial cystitis-like lower urinary tract symptoms. Int Urol Nephrol 2022, 54, 2157-2165, doi:10.1007/s11255-022-03294-2.